Uncategorised - European Medical Journal

α1-antitrypsin deficiency

Lung Disease in Never-Smokers with Severe α1-Antitrypsin Deficiency

Never-smokers with severe α1-antitrypsin deficiency can still develop lung disease, including emphysema, bronchiectasis, and airflow obstruction.

awareness

Brain Imaging Detects Signs of Awareness in Unresponsive Patients

Researchers detect hidden signs of awareness in ICU patients using fNIRS brain imaging, reshaping understanding of consciousness.

Clinician performing upper endoscopy procedure with endoscope in hospital setting

Achalasia Hospitalizations Reflect Major Decade Shift

Achalasia hospitalizations in the US increasingly feature POEM adoption alongside rising patient complexity.

Personalised Treatment Approaches in Asthma

Understanding the different endotypes and phenotypes of asthma is transforming how clinicians diagnose and manage patients. This infographic…

Pharma's role in building next-gen patient case studies

As HCPs seek richer learning experiences, interactive patient case studies are bridging the gap between data and real-world practice.

Diana Web, Institut Cochin in Paris

Hema Now: Episode 29: Inside the Tumour Microenvironment

How do leukaemic cells invade the central nervous system?

incretin autoantibodies

Incretin Autoantibodies Indicate Poor Prognosis in Diabetes

Elevated autoantibodies against incretin hormones may indicate poorer outcomes in diabetes, highlighting potential for new prognostic biomarkers.

Serum Tyrosine Predicts Hepatocellular Carcinoma and Mortality in Chronic Liver Disease

Elevated serum tyrosine predicts HCC and mortality in chronic liver disease, helping identify high-risk patients for closer monitoring.

Patient receiving immunotherapy infusion for non-small cell lung cancer in clinic

Immune Checkpoint Inhibitors Safe for HIV NSCLC

Immune checkpoint inhibitor therapy appears safe and effective for NSCLC in people living with HIV today.

Predicting Treatment Success in De Novo Small Vessel Disease

Discover how a novel angiographic index predicts treatment success in de novo small vessel disease using drug-coated balloons.